S. Feasson
Cardiology and Cardiovascular Medicine · 2008
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cardiology and Cardiovascular Medicine — 6 citations into it
Whom S. Feasson trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts S. Feasson overall
Papers from S. Feasson's perspective
Ordered by how strongly the researchers S. Feasson trusts endorse each paper. Same corpus, a different order for every researcher.
- Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (New England Journal of Medicine)
- Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. (New England Journal of Medicine)
- Rates of hippocampal atrophy correlate with change in clinical status in aging and AD (Neurology)
- Midlife vascular risk factors and late-life mild cognitive impairment (Neurology)
- Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease (Journal of Neurology Neurosurgery & Psychiatry)
- Neuropathological stageing of Alzheimer-related changes
- Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. (New England Journal of Medicine)
- Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database. (Archives of General Psychiatry)
- Guidelines for management of arterial hypertension
- Schizophrenia and increased risks of cardiovascular disease. (American Heart Journal)